Business·Industry

“No Additional Investments in the U.S. or Japan… Maximizing Use of Domestic Production Bases”—SK hynix Conference Call

JAEMIN SONG
2026-07-29 10:01:31
[Edaily JAEMIN SONG Choi Oh-hyun Reporter] “In South Korea, we plan to develop Icheon and Yongin as production hubs for next-generation DRAM and AI memory, and Cheongju as a production hub covering NAND and advanced packaging. The large-scale investment announced recently is also intended to proactively secure the infrastructure needed for the future. Going forward, when deciding on production hubs, we plan to select the optimal locations by comprehensively considering factors such as power, water supply, workforce, supply chains, and customer accessibility. However, aside from what has been announced, there are no additional investment decisions made overseas, such as in the U.S. or Japan. We will respond promptly to growing customer demand while efficiently expanding production capacity by maximizing the use of our existing production hubs.”

…SK hynix Q2 2026 Conference Call


A view of SK hynix’s headquarters in Icheon, Gyeonggi Province. (Photo: Yonhap News)

Economy

Corporation

IT·Science

Economy

Samsung Electronics’ Super-Enterprise Union: “Only DS Members Can Join”… Labor-Labor Conflict Crosses the Line (Comprehensive)

Concerns are growing that internal conflicts at SamsungElectronics—which have crossed the line with slander, exposés, and petitions—could adversely affect the company’s long-term competitiveness. In p…
2026-09-20 19:12:35

Corporation

“Is This the Next Big Thing?” From Roadshops to Olive Young—What’s Next? Will ‘Derma’ Shake Up the K-Beauty Throne?

The “formula for success” in K-Beauty distribution is changing. During the era of street shops, brands were the driving force; during the Olive Young era, product variety and discovery were key. Now, …
2026-09-20 11:28:27

IT·Science

HanmiPharm Strengthens Management of Accounts Receivable at Beijing Hanmi… “Actively Incorporating Shareholder Suggestions”

HanmiPharm(128940)HanmiPharm has taken steps to collect receivables and strengthen internal controls regarding issues with its Chinese subsidiary, Beijing HanmiPharm. This comes after some institution…
2026-09-20 16:42:02